Fidelity Investments’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.61M Buy
144,961
+21,398
+17% +$429K ﹤0.01% 2550
2025
Q4
$2.89M Buy
123,563
+50,447
+69% +$1.09M ﹤0.01% 2472
2025
Q3
$1.46M Buy
73,116
+70,726
+2,959% +$1.27M ﹤0.01% 2659
2025
Q2
$32.7K Sell
2,390
-510
-18% -$4.89K ﹤0.01% 4089
2025
Q1
$32.1K Sell
2,900
-17,071
-85% -$182K ﹤0.01% 4053
2024
Q4
$213K Sell
19,971
-3,119
-14% -$37.3K ﹤0.01% 3244
2024
Q3
$293K Buy
23,090
+19,670
+575% +$292K ﹤0.01% 3065
2024
Q2
$57.4K Buy
3,420
+189
+6% +$2.69K ﹤0.01% 3547
2024
Q1
$48.5K Sell
3,231
-1,649
-34% -$27K ﹤0.01% 3601
2023
Q4
$73.2K Sell
4,880
-39
-0.8% -$506 ﹤0.01% 3349
2023
Q3
$68.9K Buy
4,919
+4,416
+878% +$70.9K ﹤0.01% 3242
2023
Q2
$5.21K Buy
503
+49
+11% +$541 ﹤0.01% 4354
2023
Q1
$4.2K Hold
454
﹤0.01% 4434
2022
Q4
$4.03K Hold
454
﹤0.01% 4326
2022
Q3
$4K Sell
454
-86
-16% -$711 ﹤0.01% 4419
2022
Q2
$4K Buy
540
+244
+82% +$1.68K ﹤0.01% 4409
2022
Q1
$3K Buy
+296
New +$2.31K ﹤0.01% 4595
2021
Q3
Sell
-47,603
Closed -$727K 5059
2021
Q2
$727K Hold
47,603
﹤0.01% 2719
2021
Q1
$927K Hold
47,603
﹤0.01% 2596
2020
Q4
$858K Sell
47,603
-12,100
-20% -$254K ﹤0.01% 2557
2020
Q3
$1.15M Sell
59,703
-167,800
-74% -$3.8M ﹤0.01% 2402
2020
Q2
$5.94M Sell
227,503
-87,100
-28% -$2.13M ﹤0.01% 1996
2020
Q1
$5.61M Hold
314,603
﹤0.01% 1896
2019
Q4
$10.5M Sell
314,603
-273,600
-47% -$7.47M ﹤0.01% 1828
2019
Q3
$14M Hold
588,203
﹤0.01% 1708
2019
Q2
$21.1M Hold
588,203
﹤0.01% 1604
2019
Q1
$21.7M Buy
588,203
+32,200
+6% +$1.35M ﹤0.01% 1572
2018
Q4
$23.9M Hold
556,003
﹤0.01% 1488
2018
Q3
$26.3M Sell
556,003
-150,611
-21% -$7M ﹤0.01% 1569
2018
Q2
$35.2M Sell
706,614
-157,813
-18% -$9.18M ﹤0.01% 1457
2018
Q1
$43M Buy
864,427
+174,597
+25% +$8.75M 0.01% 1372
2017
Q4
$25.7M Sell
689,830
-79,400
-10% -$2.83M ﹤0.01% 1607
2017
Q3
$24.2M Hold
769,230
﹤0.01% 1627
2017
Q2
$13.9M Buy
+769,230
New +$13.4M ﹤0.01% 1822

Other funds holding URGN